Diagnostic Tools for Stargardt's: Fundus Autofluorescence & OCT Explained

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

Patients newly diagnosed with Stargardt’s disease often leave their doctor’s office with a list of unfamiliar test names – fundus autofluorescence, OCT, ERG – without a clear sense of what each one actually shows. Here’s a straightforward explanation of the main diagnostic tools used for Stargardt’s disease, and what each one is looking for.

Fundus Autofluorescence (FAF)

Fundus autofluorescence imaging captures the natural fluorescent signal given off by certain compounds within retinal cells, particularly lipofuscin – the fatty byproduct that abnormally accumulates in Stargardt’s disease due to ABCA4 gene mutations. On FAF imaging, this typically appears as a distinctive pattern of increased or decreased fluorescence around the macula, often before structural changes are clearly visible on standard eye examination. This makes FAF particularly valuable for detecting Stargardt’s disease at earlier stages, and for monitoring how the affected area changes over time.

Optical Coherence Tomography (OCT)

OCT uses light waves to create detailed cross-sectional images of the retina, allowing doctors to measure the thickness and structural integrity of different retinal layers, particularly in the macula. In Stargardt’s disease, OCT typically shows thinning or disruption of the photoreceptor layer in the affected area, and is especially useful for tracking structural progression over successive visits with objective, measurable data rather than relying solely on subjective visual acuity testing.

Electroretinogram (ERG)

While FAF and OCT assess retinal structure, ERG measures retinal function – specifically, how well photoreceptor cells respond to light stimulation. In Stargardt’s disease, ERG results can vary depending on how much of the retina is affected, with more localised macular involvement sometimes showing relatively preserved overall ERG response, while more extensive disease may show broader functional impairment. This functional data complements the structural information from FAF and OCT.

Genetic Testing as a Complementary Tool

While not an imaging tool, genetic testing for ABCA4 mutations is typically used alongside these imaging findings to confirm a Stargardt’s disease diagnosis definitively, distinguish it from other conditions with similar imaging appearances, and inform family counselling regarding inheritance risk.

Why Using Multiple Tools Together Matters

No single test is considered sufficient on its own for a confident Stargardt’s disease diagnosis. FAF and OCT provide complementary structural information, ERG adds functional context, and genetic testing provides definitive confirmation – together offering a far more complete and reliable diagnostic picture than any single test alone.

Questions Worth Asking Your Doctor

What did the fundus autofluorescence pattern specifically show, and what does that suggest about disease stage?
How has my OCT changed compared to previous scans, if this is a follow-up visit?
Has genetic testing been done to confirm the ABCA4 mutation, and what does the result show?
How often should these tests be repeated to monitor progression going forward?

What This Means in Practice

For most patients, a confident Stargardt’s disease diagnosis and an accurate understanding of disease stage relies on a combination of fundus autofluorescence, OCT, and where possible, genetic confirmation – rather than any single test in isolation. Understanding what each test is actually measuring helps patients engage more meaningfully in conversations about their diagnosis, monitoring schedule, and treatment options going forward.

Government & Regulatory References

Rare Diseases India Portal – Ministry of Health and Family Welfare, Government of India – Stargardt’s disease is classified as a rare inherited retinal disorder, and this policy outlines India’s framework for diagnosis, genetic counselling, and management support.
National Programme for Control of Blindness and Visual Impairment (NPCBVI) – Ministry of Health and Family Welfare, Government of India – the national programme addressing prevention and management of vision-impairing conditions including age-related macular degeneration.
Evidence-Based Status of Stem Cell Therapy for Human Diseases – Indian Council of Medical Research (ICMR)

Diagnostic Tools for Stargardt’s: Fundus Autofluorescence & OCT Explained